Responsible PrecliniX Kick-Off Event
The Responsible PrecliniX unit forms a hub that connects different stakeholders in preclinical research including core facilities to bring together complementing expertise and to ensure as well as to provide guidance towards robust evidence and clinical translation.
Project Responsible PrecliniX (RPX)
Translation aims to transform biomedical innovations into clinical practice. This process is challenging and requires the integration of expertise from various disciplines. To foster robust preclinical evidence generation, Responsible PrecliniX (RPX) was recently established as a research and counsel unit at the BIH QUEST Center for Responsible Research. It aims to strengthen the reliability and validity of preclinical findings to increase the probability of translational success. It is complementing the network between clinical study center, regulatory advisors, and core facilities to form a unique structure at a translational research institute. Close collaboration and establishment of communication processes between the network partners will ensure clinical relevance, fit for purpose applications, high-quality standards, and iterative translation i.e., from bench to bed and back.
RPX Kick - Off Event
This meeting should shed light on what Responsible PrecliniX does, how we operate and highlight and establish collaboration(s), handshake processes, and the integration of this unit into the existing ecosystem in translational research at BIH at Charité. Importantly, we will also highlight HOW and WHEN to approach us, our areas of expertise and how we can connect you with partners that complement your expertise.
Content -Together Towards Robust Evidence Generation
Presentations will include:
- The development and evaluation of a metric to assess internal, external, and translational validity and reliability aspects of projects
- Workflow for processes - what can we cover, where can we connect you with field-specific experts - “Joint Approaches towards Responsible Translation"
- The role of core facilities and their counseling process
- Regulatory affairs in preclinical research - when, what, how?
- Patient engagement in preclinical studies
Everybody from Charité is welcome. The meeting is particularly targeted at all relevant stakeholders at BIH, that are part of the BIH strategy, like the core facilities and the Clinical study center, as well as funding streams like SPARK and the clinician scientist program. In addition, it targets research groups and individual scientists at BIH/ Charité that aim at translating their preclinical evidence into clinical context.
Date: 4th October 2022, 4 - 6 pm
Followed by a small reception and networking event.
Format: Hybrid - everybody can attend online, there is limited space (up to 20 people) onsite.
The decision for your onsite participation will be made on a first come first serve basis. If you register early and can attend in person you have the opportunity to join us for further networking activities after the event including food and drinks.
|16:00 - 16:05||Welcome ‘why we are here?’ and introduction ‘what to expect?’||Ulf Tölch|
|16:05 - 16:20||Presentation RPX “Together towards robust evidence generation”||Natascha Drude|
|16:20 - 16:50||Key Note Patient engagement in preclinical studies||TBD|
|16:50 - 17:05||Coffee Break|
|17:05 - 17:20||Presentation Core facilities||TBD|
|17:20 - 17:35||Regulatory consideration in preclinical studies||Christoph Conrad|
|17:35 - 17:55||Open questions, guided discussion||Ulf Tölch, Natascha Drude|
|17:55 - 18:00||Closing remarks||Natascha Drude|
|18:00 - 20:00||Reception - Finger food and drinks|